Annual Shareholders Equity
$346.54 M
+$14.50 M+4.37%
December 31, 2023
Summary
- As of February 7, 2025, DAWN annual stockholders equity is $346.54 million, with the most recent change of +$14.50 million (+4.37%) on December 31, 2023.
- During the last 3 years, DAWN annual shareholders equity has risen by +$400.75 million (+739.31%).
- DAWN annual shareholders equity is now at all-time high.
Performance
DAWN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$555.46 M
+$248.73 M+81.09%
September 30, 2024
Summary
- As of February 7, 2025, DAWN quarterly stockholders equity is $555.46 million, with the most recent change of +$248.73 million (+81.09%) on September 30, 2024.
- Over the past year, DAWN quarterly shareholders equity has increased by +$208.92 million (+60.29%).
- DAWN quarterly shareholders equity is now at all-time high.
Performance
DAWN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
DAWN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.4% | +60.3% |
| 3 y3 years | +739.3% | +53.0% |
| 5 y5 years | +3346.9% | +53.0% |
DAWN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.3% | at high | +114.0% |
| 5 y | 5-year | at high | +739.3% | at high | +906.8% |
| alltime | all time | at high | +739.3% | at high | +906.8% |
Day One Biopharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $555.46 M(+81.1%) |
| Jun 2024 | - | $306.73 M(+3.3%) |
| Mar 2024 | - | $296.81 M(-14.4%) |
| Dec 2023 | $346.54 M(+4.4%) | $346.54 M(-11.1%) |
| Sep 2023 | - | $389.63 M(-8.5%) |
| Jun 2023 | - | $426.05 M(+41.8%) |
| Mar 2023 | - | $300.42 M(-9.5%) |
| Dec 2022 | $332.04 M | $332.04 M(-8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $363.08 M(-7.1%) |
| Jun 2022 | - | $390.63 M(+50.5%) |
| Mar 2022 | - | $259.60 M(-7.7%) |
| Dec 2021 | $281.15 M(-618.7%) | $281.15 M(-5.6%) |
| Sep 2021 | - | $297.67 M(-4.5%) |
| Jun 2021 | - | $311.76 M(-552.8%) |
| Mar 2021 | - | -$68.85 M(+27.0%) |
| Dec 2020 | -$54.20 M(+407.9%) | -$54.20 M |
| Dec 2019 | -$10.67 M | - |
FAQ
- What is Day One Biopharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual shareholders equity year-on-year change?
- What is Day One Biopharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly shareholders equity year-on-year change?
What is Day One Biopharmaceuticals annual stockholders equity?
The current annual shareholders equity of DAWN is $346.54 M
What is the all time high annual shareholders equity for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual stockholders equity is $346.54 M
What is Day One Biopharmaceuticals annual shareholders equity year-on-year change?
Over the past year, DAWN annual stockholders equity has changed by +$14.50 M (+4.37%)
What is Day One Biopharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of DAWN is $555.46 M
What is the all time high quarterly shareholders equity for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly stockholders equity is $555.46 M
What is Day One Biopharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, DAWN quarterly stockholders equity has changed by +$208.92 M (+60.29%)